ada glp-1 A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical News podcast, Jennifer Abbasi interviews Rita Kalyani, MD ADA 2021: Hanmi's GLP-1 drug,

only Contact Us (570)-423-7443 [email protected]

When meals are planned and balanced, theres less guesswork, fewer skipped meals, and not as many impulse food choices

[CrossRef] [PubMed] [Google Scholar] A comprehensive overview of the current status and advancements in various treatment strategies against epilepsy

Non-pharmacological approaches remain foundational for cardiac patients: Medically supervised dietary programs: Structured meal plans with registered dietitian support, emphasizing heart-healthy Mediterranean or DASH dietary patterns Cardiac rehabilitation programs: Supervised exercise training tailored to individual cardiac capacity and limitations Behavioral therapy: Cognitive-behavioral interventions addressing eating patterns, stress management, and lifestyle modification Bariatric surgery: For patients with BMI 35 kg/m with obesity-related comorbidities or BMI 40 kg/m (per NIH 1991 criteria

[DOI] [PubMed] [Google Scholar] [62].Kim M, Platt MJ, et al

I work for Cypress Healthcare here in Sacramento, and I'm here to support WQ